XRP44X inhibits Ras-induced transcription activation with the IC50 of 10 nM. XRP44X inhibits activation of the Ras-Erk-1/2 pathway by FGF-2. XRP44X is an inhibitor of Ras/Erk activation of Elk3 that also affects microtubules.
性状
Solid
IC50 & Target[1][2]
Ras
10 nM (IC50)
体外研究(In Vitro)
XRP44X is an indirect inhibitor of Net phosphorylation that acts upstream from Erk-1/2 activation. XRP44X inhibits luciferase activity with the IC50 of~10 nM.
XRP44X (10 nM) inhibits cell growth of HUVEC, NIH3T3, HCT-116, and NIH3T3–Ki-Ras cells.
XRP44X (100 nM) inhibits phosphorylation of Mek-1/2 and Raf-1.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay
Cell Line:
HUVEC, NIH3T3, HCT-116, and NIH3T3-Ki-Ras cells
Concentration:
10 nM
Incubation Time:
24, 48, 72, 96 hours
Result:
Inhibited HUVEC, HCT 116,NIH3T3, and NIH3T3-RAS cells proliferation with IC50s of 2.2±0.5 nM, 2.3±0.5 nM, 4±0.5 nM, and 2.3±0.5 nM, respectively.
Inhibited the growth of immortalized mouse fibroblasts.
Western Blot Analysis
Cell Line:
HUVEC cells
Concentration:
100 nM
Incubation Time:
Pretreated for 90 minutes
Result:
Inhibited phosphorylation of Rsk-1.
Inhibited phosphorylation of Erk-1/2 on sites required for its activation without affecting overall levels of Erk-1/2.
体内研究(In Vivo)
XRP44X may have therapeutic potential for refractory asthma.
XRP44X, an inhibitor of Ras/Erk activation of the transcription factor Elk3, inhibits tumor growth and metastasis in mice. XRP44X inhibits tumor growth and metastasis in nude mice. XRP44X decreases the growth of tumours and the formation of metastases in nude mice.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:
Male nude mice (BALB/c nu/nu)
Dosage:
1 mg/kg
Administration:
Intraperitoneal injection; treated daily for 6 days
Result:
Inhibited cell tumor formation by xenografts in nude mice.